From the category archives:

Stocks

ImmunoCellular Therapeutics (IMUC) Stock Review

July 25, 2011

In this week’s installment of highlighting investment opportunities, today, I’m going to cover ImmunoCellular Therapeutics (IMUC). Background ImmunoCellular Therapeutics is a California-based oncology firm with the lead candidate ICT-107 entering Phase II for patients with a particular form of brain cancer, glioblastoma multiforme (GBM).  IMUC’s primary candidate targets cancer stem cells via a dendritic cell-based [...]

Share
Read the full article →

CytRx Corporation Stock Review

May 19, 2011

In another installment of highlighting various investment opportunities, today, I’m going to cover CytRx Corporation (ticker: CYTR).  As a biotech guy myself, I’m always interested in up and coming biotech outfits.  Not only do they often have the potential to jump 100% or more in a single day when a pivotal drug study is released [...]

Share
Read the full article →

Why ETFs are So Much Better Than Mutual Funds and Stocks

January 29, 2010

The benefits of ETFs over traditional investment vehicles like stocks and mutual funds have not gone unnoticed by investors and advisers alike. With inflows into ETFs exploding annually while hedge funds and other actively managed funds were brought back to earth during the financial meltdown, it’s worth considering just what makes ETFs so much better [...]

Share
Read the full article →